ClariVest Asset Management LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$233
-22.6%
7,3810.0%0.01%
-13.3%
Q2 2023$301
+2.4%
7,381
-6.3%
0.02%
+15.4%
Q1 2023$294
+7.3%
7,881
+0.3%
0.01%0.0%
Q4 2022$274
-99.9%
7,859
-0.2%
0.01%
-38.1%
Q3 2022$441,000
+8.1%
7,872
-0.3%
0.02%
+16.7%
Q2 2022$408,000
-28.9%
7,8940.0%0.02%
-21.7%
Q1 2022$574,000
-38.5%
7,894
-0.1%
0.02%
-20.7%
Q4 2021$933,000
-17.4%
7,898
-6.1%
0.03%
-19.4%
Q3 2021$1,129,000
+88.8%
8,412
+127.7%
0.04%
+80.0%
Q2 2021$598,000
+564.4%
3,694
-42.4%
0.02%
+900.0%
Q1 2017$90,000
-24.4%
6,412
-29.4%
0.00%
-33.3%
Q4 2016$119,000
-25.2%
9,077
-2.9%
0.00%
-40.0%
Q3 2016$159,0009,3440.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders